Skip to main content

Table 5 Overall frequency of SSIs and serious SSIs, and listing of all SSIs

From: A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery

 

HA/CMC powder (n = 105)

No adhesion barrier (n = 104)

P value

At least 1 SSI, n (%)

22 (21.0)

15 (14.4)

0.216

   Deep

13 (12.4)

8 (7.7)

0.260

   Incisional

13 (12.4)

7 (6.7)

0.165

At least 1 serious SSI, n (%)

13 (12.4)

9 (8.7)

0.380

   Deep

12 (11.4)

8 (7.7)

0.359

   Incisional

2 (1.9)

1 (1.0)

1.000

All SSIs, n (%)

   

 Infections and infestations

20 (19.0)

11 (10.6)

   Incision site abscess

5 (4.8)

3 (2.9)

   Pelvic abscess

5 (4.8)

2 (1.9)

   Abdominal wall abscess

4 (3.8)

2 (1.9)

   Abdominal abscess

4 (3.8)

0

   Incision site infection

1 (1.0)

2 (1.9)

   Abscess intestinal

1 (1.0)

1 (1.0)

   Abdominal infection

1 (1.0)

0

   Bacteraemia

1 (1.0)

0

   Postoperative abscess

1 (1.0)

0

   Septic shock

0

1 (1.0)

   Subcutaneous abscess

1 (1.0)

0

 Injury, poisoning, and procedural complications

6 (5.7)

4 (3.8)

   Anastomotic fistula

4 (3.8)

4 (3.8)

   Gastrointestinal anastomotic leak

1 (1.0)

0

   Incision site complication

1 (1.0)

0

 Gastrointestinal disorders

2 (1.9)

5 (4.8)

   Peritonitis

2 (1.9)

3 (2.9)

   Colonic fistula

0

1 (1.0)

   Gastrointestinal inflammation

0

1 (1.0)

  1. Shown by system organ class and preferred term.
  2. –, Statistical significance not tested.
  3. SSI, Surgical site infection.